Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(507/week)
Manufacturing
(335/week)
Energy
(278/week)
Technology
(347/week)
Other Energy
(240/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
CNS Pharmaceuticals, Inc.
Aug 11, 2020
CNS Pharmaceuticals to Provide Second Quarter 2020 Business Update on Thursday, August 13, 2020
Jul 15, 2020
CNS Pharmaceuticals Completes Drug Product Manufacturing Strategy for Berubicin
Jul 08, 2020
CNS Pharmaceuticals Completes Active Ingredient Shipments to Manufacturers
Jun 30, 2020
CNS Pharmaceuticals Engages Berry Consultants to Advise Phase 2 Trial Design
Jun 23, 2020
CNS To Present at the Life Sciences Investor Forum
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Jun 09, 2020
CNS Announces Highlights from Annual Meeting of Shareholders
May 27, 2020
CNS Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
May 27, 2020
CNS Provides Update on Development Agreement for WP1122
May 18, 2020
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
May 11, 2020
CNS Provides Additional Comments Regarding Trading Halt
May 04, 2020
CNS Pharmaceuticals Announces Trading Halt
Apr 23, 2020
CNS Pharmaceuticals Announces Filing of FDA Orphan Drug Designation for Brain Cancer Drug Berubicin
Apr 22, 2020
CNS Pharmaceuticals to Host Shareholder Webinar Today to Discuss Coronavirus Collaboration, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin
Apr 15, 2020
CNS Pharmaceuticals Announces Shareholder Webinar to Discuss Collaboration with WPD Pharmaceuticals for Developing Coronavirus Drug Candidates, the Significance of WP1244, and an Update on the Cancer Free Survivor Treated with Berubicin
Apr 13, 2020
CNS Pharmaceuticals Announces Independent University Research Confirms Active Compound in WP1122 Completely Prevents Coronavirus Replication In Vitro; WP1122 is Subject to Development Agreement with WPD Pharmaceuticals
Mar 23, 2020
CNS Pharmaceuticals Signs Agreement with WPD Pharmaceuticals to Develop Drug Candidates for a Range of Viruses including Coronavirus for International Markets
Mar 12, 2020
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
Mar 05, 2020
CNS Pharmaceuticals to Report Fourth Quarter 2019 Financial Results on March 12, 2020
Mar 03, 2020
CNS Pharmaceuticals Announces Brain Cancer Patient from Berubicin Phase 1 Trial Remains Cancer Free
‹‹
Page 2
››
Latest News
Apr 19, 2024
Two Top Rating Agencies Reaffirm Metropolitan’s Strong Credit Ratings
Apr 19, 2024
Mativ Announces Conference Call to Discuss First Quarter 2024 Results
Apr 19, 2024
LSI Industries Acquires EMI Industries, Expanding Store Fixtures and Food Service Equipment Business
Apr 19, 2024
Anue Water Technologies Adds Four New Channel Partners to Serve Wastewater Treatment Customers in California...
Apr 19, 2024
Kermit Facility Operational Update
Apr 19, 2024
IDACORP, Inc. Declares Dividend
Apr 19, 2024
Geospace Technologies Releases Lightweight, Long Lasting Land Seismic Data Acquisition Node
Apr 19, 2024
Atmus Filtration Technologies to Announce First Quarter 2024 Results on May 3, 2024
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events